0001665329-16-000002.txt : 20160229 0001665329-16-000002.hdr.sgml : 20160229 20160229161218 ACCESSION NUMBER: 0001665329-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 EFFECTIVENESS DATE: 20160229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MTS Health Investors IV, L.P. CENTRAL INDEX KEY: 0001665329 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-258278 FILM NUMBER: 161467842 BUSINESS ADDRESS: STREET 1: 623 FIFTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-887-2100 MAIL ADDRESS: STREET 1: 623 FIFTH AVENUE, 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0707 D LIVE 0001665329 MTS Health Investors IV, L.P. c/o MTS Health Investors 623 Fifth Avenue, 16th Floor New York NY NEW YORK 10022 212-887-2100 DELAWARE None None Limited Partnership true 2015 Curtis S. Lane c/o MTS Health Investors 623 Fifth Avenue, 16th Floor New York NY NEW YORK 10022 Executive Officer Oliver T. Moses c/o MTS Health Investors 623 Fifth Avenue, 16th Floor New York NY NEW YORK 10022 Executive Officer Alexander Buzik c/o MTS Health Investors 623 Fifth Avenue, 16th Floor New York NY NEW YORK 10022 Executive Officer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.1 3C.7 false 2016-02-12 false true true false 0 Probitas Funds Group, LLC 115876 None None 425 California Street Suite 2300 San Francisco CA CALIFORNIA 94104 VT VERMONT IL ILLINOIS UT UTAH NY NEW YORK CT CONNECTICUT CA CALIFORNIA MS MISSISSIPPI LA LOUISIANA VA VIRGINIA OH OHIO TX TEXAS FL FLORIDA NC NORTH CAROLINA PA PENNSYLVANIA ND NORTH DAKOTA false 300000000 155015000 144985000 The general partner reserves the right to offer a greater or lesser amount of limited partner interests. false 24 0 true 0 true Such fees, if any, will only be paid upon the sale of interests to certain investors and such amounts will not be finalized until completion of the offering. 0 true The general partner is entitled to a performance allocation. The investment manager is entitled to a management fee. The performance allocation and management fee are fully discussed in the Issuer's confidential offering materials. false MTS Health Investors IV, L.P. Curtis S. Lane Curtis S. Lane Senior Managing Director 2016-02-12